Category: Cancer Treatment
Global Cancer Treatment
-
Cancer Gene Therapy Market Size, Trends, Analysis, and Outlook By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), By End-User (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... global Cancer Gene Therapy market size is poised to register 20.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Gene Therapy ... Read More
-
Next Generation Cancer Diagnostics Market Size, Trends, Analysis, and Outlook By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, 2024-2030
... Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, ... Read More
-
Global Head and Neck Cancer Drugs & Therapeutics Market Growth (Status and Outlook) 2024-2030
... at US$ million in 2023. With growing demand in downstream market, the Head and Neck Cancer Drugs & Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % ... Read More
-
Mesenchymal Stem Cells Market Size, Trends, Analysis, and Outlook By Product & Services (Products, Services), By Workflow (Cell Sourcing & Isolation, Culture & Cryopreservation, Differentiation, Characterization), By Type (Autologous, Allogeneic), By Source of Isolation (Bone Marrow, Cord Blood, Peripheral BloodFallo, pian Tube, Fetal Liver, Lung, Adipose Tissues), By Indication (Bone And Cartilage Repair, Cardiovascular Disease, Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD, Others), By Application (Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Others), by Region, Country, Segment, and Companies, 2024-2030
... Marrow, Cord Blood, Peripheral BloodFallo, pian Tube, Fetal Liver, Lung, Adipose Tissues), By Indication (Bone And Cartilage Repair, Cardiovascular Disease, Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD, Others), By Application (Disease Modelling, Drug Development ... Read More
-
Generic Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Type (Simple Generics, Specialty Generics, Biosimilar), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals ... Read More
-
Smart Biopsy Devices Market Size, Trends, Analysis, and Outlook By Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Others), By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Others), By Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Others), By End-user (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), by Region, Country, Segment, and Companies, 2024-2030
... Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Others), By End-user (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), by Region, Country, Segment, and Companies, 2024-2030 The global Smart Biopsy Devices market size is poised to ... Read More
-
Drug Delivery Across Blood-Brain Barrier Market Size, Trends, Analysis, and Outlook By Drug Delivery Technology (Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion, Others), By Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others), by Region, Country, Segment, and Companies, 2024-2030
... Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Drug Delivery Across Blood-Brain Barrier market size is poised to register 19.61% growth from 2024 to 2030, ... Read More
-
Global HER2 Antibodies Market Growth (Status and Outlook) 2024-2030
... downstream market, the HER2 Antibodies is forecast to a readjusted size of US$ 11550 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global ... Read More
-
Computer-Aided Detection Market Size, Trends, Analysis, and Outlook By Application (Tuberculosis, Breast cancer, Lung cancer, Colon/rectal cancer, Prostate cancer, Liver cancer, Bone cancer, Neurological/musculoskeletal/cardiovascular Indications), By Indication (X-ray imaging, Computed tomography, Ultrasound imaging, Magnetic resonance imaging, Nuclear medicing imaging, Others), by Region, Country, Segment, and Companies, 2024-2030
... imaging, Nuclear medicing imaging, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Computer-Aided Detection market size is poised to register 6.57% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Point of Care Diagnostics Market Size, Trends, Analysis, and Outlook By Product(Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease , Cardiac Markers, Thyroid, Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030
... Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030 The global Point ... Read More
-
The 2025-2030 World Outlook for Liposomal Doxorubicin
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Photodynamic Therapies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Chronic Lymphocytic Leukemia
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Leukemia Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Women's Diagnostic Breast Cancer Testing
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for PDX Models
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Screening Software
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for NDDS in Cancer Therapies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Checkpoint Inhibitors for Anti-Cancer Treatments
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Cancer Profiling Technologies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
